Details
Category: Volume 08 Issue 06 June 2020
Hits: 979

Title: Inflammatory Verrucous Epidermal Nevus: Treated with Surgical Excision

Authors: Ravinder Singh, Abhishek Thakur, Shikha Verma

 DOI: https://dx.doi.org/10.18535/jmscr/v8i6.49

Abstract

The "inflammatory linear verrucous epidermal nevus” is a rare disease, consisting of hyperplasia of the normal components of the epidermis typically present at birth, but can occur anytime during childhood and may rarely appear in adulthood. Its clinical features include erythematous and hyperkeratotic, warty, sometimes psoriasiform or lichenoid patches with a typical linear arrangement. They usually occur on a limb following the lines of Blaschko, more rarely on the trunk, in a curvilinear pattern, or in different areas. We present a 17 years old female with inflammatory linear verrucous epidermal nevus on right side of her abdomen.

References

  1. Brandling-Bennett HA (University of Washington, Seattle Children’s Hospital, Seattle, WA 98105, USA), Morel KD. Epidermal nevi. Pediatr Clin North Am 2010 Oct;57(5):1177- 1198.
  2. Solomon LM, Fretzin DF, Dewald RL. The epidermal nevus syndrome. Arch Dermatol 1968;97:273-85.
  3. Gon AS, Minelli L, Franzon PG. A case for diagnosis. Ann Bras Dermatol 2010;85:729-31.
  4. Panagiotopoulos A (3rd Dermatology Clinic, Andreas Sygros Hospital for Skin Diseases, Athens, Greece.), Chasapi V, Nikolaou V, Stavropoulos P, Kafouros K, Petridis A, Katsambas A. Assessment of cryotherapy for the treatment of Verrucous Epidermal naevi. Acta Derm Venereol 2009;89(3):292-294.
  5. Hafner C (Department of Dermatology, University of Regensburg, Germany. This email address is being protected from spambots. You need JavaScript enabled to view it.. de), Vanoers J, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff E, Hartmann A. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006 Aug;116(8):2201-2207.
  6. Cassetty CT (Ronald O. Perelman Department of Dermatology, New York University, USA), Leonard AL. Epidermal nevus. Dermatol Online J 2003 Oct;9(4):43.
  7. Levenberg ME, Ermolovich T, Purcell SM. Management of epidermal nevi in the setting of epidermal syndrome. JAOCD 2006;6:58-61.
  8. Kim JJ (Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA), Chang MW, Shwayder T. Topical tretinoin and 5-fluorouracil in the treatment of linear verrucousepi- dermal nevus. J Am Acad Dermatol 2000 Jul;43(1 Pt 1):129-132.
  9. Altman J, Mehregan AH. Inflammatory linear verrucosae epidermal nevus. Arch Dermatol 1971;104:385-9.
  10. Morag C, Metzker A. Inflammatory linear verrucous epidermal nevus: Report of seven new cases and review of literature. Pediatr Dermatol 1985;3:15-8.
  11. Gorlin RJ, Cohen MM, Stefen LL (Epidermal nevus syndrome). In: Syndromes of the head and neck, 3rd ed. New York: Oxford University Press; 1990. p. 362-6.
  12. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Epidermal nevus. In: Fitzpatrick’s Dermatology in general medicine, Vol. 1, 5th ed. New York: McGraw Hill, Inc.; 1999. p. 876-8.
  13. Boyce S, Alster TS. CO2 Laser treatment of epidermal nevi: Long term success. DermatolSurg 2002;28:611-4.

Corresponding Author

Shikha Verma

Senior Resident, Department of Pediatrics Dr RPGMC Kangra H.P India